Prostate Specific Membrane Antigen (PSMA)
Showing 26 - 50 of >10,000
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy
Enrolling by invitation
- Castration-Resistant Prostate Carcinoma
- +2 more
- Computed Tomography
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 16, 2023
Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)
Recruiting
- Salivary Gland Cancer
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Oct 27, 2022
Prostate Cancer Trial in Brest (PSMA PET/CT)
Recruiting
- Prostate Cancer
- PSMA PET/CT
-
Brest, FranceCHRU de Brest
Jul 15, 2021
PET/CT Characterization of Treatment Resistance
Recruiting
- Prostate Cancer
- F-fluorodeoxyglucose positron emission tomography (FDG PET)
- prostate-specific membrane antigen positron emission tomography (PSMA PET)
-
Madison, WisconsinUniversity of Wisconsin
Jan 24, 2023
bIoCHEmical Relapse After Prostatectomy-PSICHE
Recruiting
- Prostate Cancer
- +3 more
-
Florence, ItalyAOU Careggi Radiation Oncology Unit
Aug 24, 2021
Hepatocellular Carcinoma Trial in Rochester (Gallium Ga 68 Gozetotide, Hepatic Artery Embolization, Positron Emission Tomography
Recruiting
- Hepatocellular Carcinoma
- Gallium Ga 68 Gozetotide
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 11, 2023
Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,
Not yet recruiting
- Prostate Adenocarcinoma
- +3 more
- Apalutamide
- +7 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- +2 more
- 177Lu HTK03170
- 68Ga-HTK03149
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 28, 2022
18F Prostate-specific Membrane Antigen PET/CT in Prostate Cancer
Recruiting
- Prostatic Neoplasms
- Positron emission tomography/computerized tomography (PET/CT)
-
Xi'an, Shaanxi, ChinaFirst Affiliate Hospital of Xi'an Jiaotong University
Mar 23, 2022
Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)
Not yet recruiting
- Medullary Thyroid Cancer
- +3 more
-
Groningen, NetherlandsUniversity Medical Centre Groningen
Sep 8, 2022
Prostate Cancer Trial in Vienna (PSMA PET Scan, FDHT PET Scan)
Recruiting
- Prostate Cancer
- PSMA PET Scan
- FDHT PET Scan
-
Vienna, AustriaMedical University of Vienna
Oct 25, 2021
Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.11GBq of 177Lu-EB-PSMA-617, 2.00 GBq of 177Lu-EB-PSMA-617,
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- 1.11GBq of 177Lu-EB-PSMA-617
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
May 6, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Apalutamide
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 20, 2023
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,
Not yet recruiting
- Prostate Adenocarcinoma
- +2 more
- Biospecimen Collection
- +6 more
- (no location specified)
Mar 28, 2023
Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Palo Alto (68Ga-PSMA-11, Magnetic resonance imaging
Completed
- Stage II Prostate Adenocarcinoma
- Stage III Prostate Adenocarcinoma
- 68Ga-PSMA-11
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Mar 2, 2022
Prostate Cancer Trial in Turku (GnRH antagonist)
Recruiting
- Prostate Cancer
- GnRH antagonist
-
Turku, FinlandTurku University Hospital
Apr 8, 2021
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on
Terminated
- Castration-Resistant Prostate Carcinoma
- +4 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 19, 2022
Metastatic Prostate Adenocarcinoma Trial in New York (68Ga-PSMA-cyclotron Versus 68Ga-PSMA-generator)
Completed
- Metastatic Prostate Adenocarcinoma
- 68Ga-PSMA-cyclotron Versus 68Ga-PSMA-generator
-
New York, New YorkWeill Cornell Medicine
Feb 1, 2022
Prostate Cancer Patients Treated With Lutetium - Prostate
Recruiting
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- WB-MRI
-
Meldola, Forlì-Cesena, Italy
- +1 more
Jan 12, 2022
Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,
Recruiting
- Breast Carcinoma
- +10 more
- Computed Tomography
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Nov 29, 2022
Adenocarcinoma of the Prostate, Stage IIB Prostate Cancer, Stage III Prostate Cancer Trial in Duarte (biological, procedure,
Active, not recruiting
- Adenocarcinoma of the Prostate
- +3 more
- anti-PSMA monoclonal antibody MDX1201-A488
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Los
Terminated
- Biochemically Recurrent Prostate Carcinoma
- +5 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUniversity of California at Los Angeles / Jonsson Comprehensive
Oct 19, 2022
Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA
Recruiting
- Prostatic Neoplasms
- Radical prostatectomy (RP)
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Jul 14, 2023
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial in Philadelphia
Recruiting
- Prostate Adenocarcinoma
- +2 more
- MRI-guided Intensity-Modulated Radiation Therapy
- +7 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 4, 2023